AN AUDIT OF THE TREATMENT OF PSORIATIC ARTHRITIS WITH BIOLOGICS

被引：0
|
作者：
Rawlings, Charlotte [1 ]
Negi, Anurag [1 ]
Choy, Ernest [1 ]
机构：
[1] Univ Wales Hosp, Rheumatol, Cardiff CF4 4XW, S Glam, Wales
来源：
RHEUMATOLOGY | 2015年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E76
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [31] Biologics gone viral: Perceptions of biologics within online psoriasis and psoriatic arthritis communities
    Maynard, N.
    Mehta, M. D.
    Reddy, R.
    Yee, D.
    Zagona-Prizio, C.
    Khan, S.
    Khan, S.
    Armstrong, A. W.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S55 - S55
  • [32] Audit of vaccination in patients on Biologics treatment
    Elmileik, H.
    Hussein, M.
    Harrington, N.
    Reynolds, H.
    Silke, C.
    Whelan, B.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : 78 - 78
  • [33] Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis
    Mease, Philip J.
    Reddy, Soumya
    Ross, Sarah
    Lisse, Jeffrey R.
    Reis, Paulo
    Griffing, Kirstin
    Sapin, Christophe
    Vadhariya, Aisha
    Furst, Daniel E.
    [J]. RMD OPEN, 2024, 10 (01):
  • [34] Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression
    Druyts, E.
    Palmer, J. B.
    Balijepalli, C.
    Chan, K.
    Fazeli, M. S.
    Herrera, V.
    Jansen, J. P.
    Park, J. J. H.
    Kanters, S.
    Reimold, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (04) : 681 - 688
  • [35] Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany
    Gandjour, Afschin
    Ostwald, Dennis A.
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2020, 18 (01) : 109 - 125
  • [36] Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective
    Aiello, Eleonora
    Manuel Bianculli, Pablo
    Bhattacharyya, Devarshi
    Gunda, Praveen
    Citera, Gustavo
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2019, 20 : 86 - 94
  • [37] Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany
    Afschin Gandjour
    Dennis A. Ostwald
    [J]. Applied Health Economics and Health Policy, 2020, 18 : 109 - 125
  • [38] Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development
    Floris, Alberto
    Mugheddu, Cristina
    Sichi, Leonardo
    Anedda, Jasmine
    Frau, Alessia
    Sorgia, Jessica
    Li Volsi, Laura
    Paladino, Maria Teresa
    Congia, Mattia
    Chessa, Elisabetta
    Angioni, Maria Maddalena
    Naitza, Micaela
    Ferreli, Caterina
    Piga, Matteo
    Atzori, Laura
    Cauli, Alberto
    [J]. RHEUMATOLOGY, 2024,
  • [39] OBESITY IS ASSOCIATED WITH PSORIATIC ARTHRITIS AND CONTRIBUTES TO THE INCREASED USE OF BIOLOGICS
    Cetin, P.
    Keser, M.
    Solmaz, D.
    Sent, G.
    Zengin, B.
    Sari, I.
    Akkoc, N.
    Onen, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1168 - 1168
  • [40] Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis Reply
    Singla, Shikha
    Putman, Michael
    Liew, Jean
    Gordon, Kenneth
    [J]. LANCET RHEUMATOLOGY, 2023, 5 (06): : E313 - E313
12345